A network of clinical research sites that powers clinical trials for large pharmaceutical companies. It uses technology to efficiently connect patients needing trial access with pharmaceutical companies seeking to accelerate patient recruitment, thereby reducing the high costs and time associated with running clinical trials.
Opportunity6.2
Why now
Increasing complexity of drug development, intense demand for faster time-to-market for new therapies, and the growing adoption of digital health solutions and patient engagement platforms.
Market gap
An efficient, tech-enabled solution to streamline patient recruitment and accelerate the overall timeline and reduce costs of clinical trials.
Business fit
Type
Healthcare Technology / Service Network
Target
Pharmaceutical companies (e.g., Pfizer, Novartis, Novoderm) seeking to accelerate clinical trials and patients needing access to advanced experimental treatments.
Revenue
The business was "pretty successful and ended up selling that business," serving large pharmaceutical companies with substantial budgets (e.g., Pfizer, Novartis). High revenue potential due to the critical and costly nature of clinical trials.
Founder
Entrepreneur with deep healthcare industry experience, a strong technology background, and the capability to navigate complex regulatory and scientific landscapes while scaling operations.
Scores
Problem
9.0
Feasibility
7.0
Why now
8.0
Go-to-market
5.0
Confidence
9.0
Proof signals
The business was "pretty successful and ended up selling that business."
Counted major pharmaceutical companies (Pfizer, Novartis, Novoderm) as customers.
Successfully used technology to solve a critical bottleneck (patient recruitment) in clinical trials.
Keyword demand
Keyword
Volume
Growth
Clinical trials
no data
no data
Pharmaceutical R&D
110/mo
-19% YoY
Patient recruitment
260/mo
-81% YoY
Healthcare technology
2,900/mo
-64% YoY
US English Google Ads volume from DataForSEO; growth uses returned monthly search history.